Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v13-FR | Version v4-FR | |
|---|---|---|
| Language | French | French |
| Date Updated | 2023-07-10 | 2023-05-05 |
| Drug Identification Number | 02047667 | 02047667 |
| Brand name | MERSYNDOL WITH CODEINE | MERSYNDOL WITH CODEINE |
| Common or Proper name | MERSYNDOL | MERSYNDOL |
| Company Name | SANOFI-AVENTIS CANADA INC | SANOFI-AVENTIS CANADA INC |
| Ingredients | ACETAMINOPHEN DOXYLAMINE SUCCINATE CODEINE PHOSPHATE | ACETAMINOPHEN DOXYLAMINE SUCCINATE CODEINE PHOSPHATE |
| Strength(s) | 325MG 5MG 8MG | 325MG 5MG 8MG |
| Dosage form(s) | TABLET | TABLET |
| Route of administration | ORAL ORAL | ORAL ORAL |
| Packaging size | 100 | 100 |
| ATC code | N02BE | N02BE |
| ATC description | OTHER ANALGESICS AND ANTIPYRETICS | OTHER ANALGESICS AND ANTIPYRETICS |
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | 2023-05-08 | 2023-05-08 |
| Actual start date | 2023-05-08 | |
| Estimated end date | 2023-07-07 | 2023-05-31 |
| Actual end date | 2023-07-07 | |
| Shortage status | Resolved | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | Supply delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. | Supply delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. |
| Health Canada comments |